1-3 of 3
Pascal Bleuzen
Close
Sort by
Journal Articles

Epoetin Beta (Neorecormon®) Treatment for Anemia of Patients with Non-Myeloid Hematological Malignancy under Chemotherapy: Results of a Large Prospective Cohort Study.

Corinne Haïoun, Norbert Ifrah, Philippe Casassus, Bruno Audhuy, Malek Aoudjhane, Jamile Frayfer, Stephanie Rouanet, Pascal Bleuzen, Arash Jenabian, Thierry Facon
Journal: Blood
Blood (2007) 110 (11): 3777.
https://doi.org/10.1182/blood.V110.11.3777.3777
Published: 2007
Journal Articles

Adenovirus-Interferon-g (TG1042) Demonstates Clinical Activity in Relapsing Primary Cutaneous Lymphoma (PCL): A Phase I/II Multicentric Trial.

Mirjana Urosevic, MD, Thomas E. Luger, MD, Wolfram Sterry, MD, Brigitte Dreno, MD, PhD, Olivier Dereure, MD, Marion Baudard, MD, PhD, Martine Bagot, MD, PhD, Pascal Bleuzen, MD, Jean-Francois Rossi, MD, Rheinard Dummer, MD
Journal: Blood
Blood (2005) 106 (11): 1497.
https://doi.org/10.1182/blood.V106.11.1497.1497
Published: 2005
Journal Articles

Adenovirus-mediated intralesional interferon-γ gene transfer induces tumor regressions in cutaneous lymphomas

Clinical Trials & Observations
Reinhard Dummer, Jessica C. Hassel, Friederike Fellenberg, Stefan Eichmüller, Tanja Maier, Philippe Slos, Bruce Acres, Pascal Bleuzen, Vincent Bataille, Patrick Squiban, Günter Burg, Mirjana Urosevic
Journal: Blood
Blood (2004) 104 (6): 1631–1638.
https://doi.org/10.1182/blood-2004-01-0360
Published: 2004